Dual HDAC/PI3K Inhibitors Trigger Apoptosis in p53-Mutant Lymphoma
In a groundbreaking study set to redefine therapeutic strategies in oncology, researchers have unveiled a potent combination therapy targeting p53-mutant diffuse large B-cell lymphoma (DLBCL),...
















